Poorly differentiated (anaplastic) seminoma of the testis
- 1 May 1984
- Vol. 53 (9) , 1991-1994
- https://doi.org/10.1002/1097-0142(19840501)53:9<1991::aid-cncr2820530931>3.0.co;2-6
Abstract
Anaplastic seminoma constitutes approximately 17% of total experience with seminoma at Memorial Sloan-Kettering Cancer Center. Among 25 previosly untreated patients, 11 (44%) were clinical Stage I, and 14 (56%) were clinical Stage II or III. Treatment of these 25 patients with the same regimens employed for classical seminoma yielded an overall 80% 5-year apparent cure rate. Survival rates were poor in eight previously treated patients referred with recurrence.This publication has 12 references indexed in Scilit:
- Elevated serum alphafetoprotein and seminoma clinical evidence for a histologic continuum?Cancer, 1982
- Ultrastructural studies of xenografted human germ cell tumorsCancer, 1982
- Combined chemotherapy and surgery in treatment of advanced germ-cell tumorsCancer, 1981
- Hypothesis: when is a seminoma not a seminoma?Journal of Clinical Pathology, 1981
- Anaplastic seminoma.An analysis of 77 patientsCancer, 1979
- Anaplastic seminoma of the testis.Ultrastructural analysis of three casesCancer, 1978
- Anaplastic seminomaCancer, 1977
- Anaplastic SeminomaJournal of Urology, 1975
- Testicular tumors.Epidemiologic, etiologic, and pathologic featuresCancer, 1973
- Treatment and Prognosis in Seminoma of the TestisJournal of Urology, 1968